These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1268785)

  • 21. Poliomyelitis immunity status in Italian and foreign subjects.
    Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
    Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the problem of revaccination against poliomyelitis. Results of a reinfection experiment using the poliovirus type 1, strain "LSc, 2ab (Sabin)". 4 and half years following original vaccination].
    Kuwert E; Posch J; Lagarie G
    Med Klin; 1968 May; 63(18):701-7. PubMed ID: 4305218
    [No Abstract]   [Full Text] [Related]  

  • 23. [Poliomyelitis in The Netherlands, 1979-1991: immunity and exposure].
    Rümke HC; Oostvogel PM; van der Veer M; van Steenis G; van Loon AM
    Ned Tijdschr Geneeskd; 1993 Jul; 137(28):1380-6. PubMed ID: 8240513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Poliomyelitis associated with a vaccine: 2 clinical cases].
    González E; Cordero J
    Rev Med Chil; 1988 May; 116(5):461-4. PubMed ID: 2854294
    [No Abstract]   [Full Text] [Related]  

  • 27. Antipoliomyelitis program in Brazil; a erologic study of immunity levels.
    de Brito Bastos NC; Carvalho Filho ES de+CARVALHOAAFILHO ES; Schatzmayr H; Homma A; Chaves J
    Bull Pan Am Health Organ; 1974; 8(1):54-65. PubMed ID: 4423450
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody persistence after primary immunization with trivalent oral poliovirus vaccine.
    Krugman RD; Hardy GE; Sellers C; Parkman PD; Witte JJ; Meyer BC; Meyer HM
    Pediatrics; 1977 Jul; 60(1):80-2. PubMed ID: 195265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3.
    Böthig B; Danes L; Dittmann S
    Bull World Health Organ; 1990; 68(5):597-600. PubMed ID: 1963118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunity of children and adolescents to poliomyelitis before and after type 3 oral vaccination, and immunity of unvaccinated infants in the Olsztyn Province].
    Rodkiewicz T; Weglińska T
    Przegl Epidemiol; 1972; 26(2):201-4. PubMed ID: 5070976
    [No Abstract]   [Full Text] [Related]  

  • 31. [Revaccination of school children with a live vaccine against poliomyelitis].
    Koza J; Matyásová I; Skovránek V; Danes L; Losová M
    Cesk Pediatr; 1983 Apr; 38(4):207-11. PubMed ID: 6303606
    [No Abstract]   [Full Text] [Related]  

  • 32. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The status of poliomyelitis in Venezuela.
    Echezuría E
    Bull Pan Am Health Organ; 1974; 8(1):66-71. PubMed ID: 4371606
    [No Abstract]   [Full Text] [Related]  

  • 34. Absence of humoral immunity to poliovirus in vaccinated individuals.
    Beuen K; White R; Kobayashi R; Farrell C
    Nebr Med J; 1988 Feb; 73(2):40-4. PubMed ID: 2832773
    [No Abstract]   [Full Text] [Related]  

  • 35. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 36. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Poliomyelitis immunity status in the centro-meridional Italy].
    Ribera G; Angelillo IF; Ricciardi G; Grasso GM; Villari P
    Ann Ig; 1995; 7(6):421-9. PubMed ID: 8663971
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunity to poliomyelitis.
    Schoub BD; Johnson S; McAnerney JM
    Lancet; 1990 Jul; 336(8707):126. PubMed ID: 1975315
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunity to poliovirus in a junior high school population in Palermo.
    Natoli D; Milici M; Brai M
    Ann Sclavo; 1980; 22(4):633-9. PubMed ID: 6264871
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunity to poliomyelitis in children, aged 0-12 yrs. residents of São Paulo, Brazil, and treated at the Hospital Menino Jesus].
    Barbosa V; Stewien KE
    Rev Saude Publica; 1975 Jun; 9(2):137-53. PubMed ID: 1181647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.